Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Transcriptomic molecular markers for screening human colon cancer in stool and tissue.

Ahmed FE, Vos P, iJames S, Lysle DT, Allison RR, Flake G, Sinar DR, Naziri W, Marcuard SP, Pennington R.

Cancer Genomics Proteomics. 2007 Jan-Feb;4(1):1-20.

2.

Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.

Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Sinar DR, Naziri W, Marcuard SP.

Cancer Genomics Proteomics. 2009 Sep-Oct;6(5):281-95.

3.

Standardization for transcriptomic molecular markers to screen human colon cancer.

Ahmed FE, Vos PW, Ijames S, Lysle DT, Flake G, Sinar DR, Naziri W, Marcuard SP.

Cancer Genomics Proteomics. 2007 Nov-Dec;4(6):419-31.

4.

Molecular markers for human colon cancer in stool and blood identified by RT-PCR.

Ahmed FE, Vos P.

Anticancer Res. 2004 Nov-Dec;24(6):4127-34.

5.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
6.

Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.

Ahmed FE, Amed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Allison RR.

Cancer Genomics Proteomics. 2012 Jul-Aug;9(4):179-92.

PMID:
22798503
7.

Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis.

Ahmed FE, James SI, Lysle DT, Dobbs LJ Jr, Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Allison RR.

Dig Dis Sci. 2004 Nov-Dec;49(11-12):1889-98.

PMID:
15628722
8.

Clusterin in stool: a new biomarker for colon cancer screening?

Pucci S, Bonanno E, Sesti F, Mazzarelli P, Mauriello A, Ricci F, Zoccai GB, Rulli F, Galatà G, Spagnoli LG.

Am J Gastroenterol. 2009 Nov;104(11):2807-15. doi: 10.1038/ajg.2009.412. Epub 2009 Jul 21.

PMID:
19623170
9.
10.

miRNA as markers for the diagnostic screening of colon cancer.

Ahmed FE.

Expert Rev Anticancer Ther. 2014 Apr;14(4):463-85. doi: 10.1586/14737140.2014.869479. Epub 2014 Mar 3. Review.

PMID:
24580550
11.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
12.

SFRP2 methylation in fecal DNA--a marker for colorectal polyps.

Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, Müller HM.

Int J Colorectal Dis. 2008 Jan;23(1):15-9. Epub 2007 Jul 17.

PMID:
17639423
13.

Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment.

Ahmed FE.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2003 Nov;21(2):65-131. Review.

PMID:
15845222
14.

Detecting colorectal cancer in stool with the use of multiple genetic targets.

Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D'Allessio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuber A, Kinzler KW, Vogelstein B, Jen J.

J Natl Cancer Inst. 2001 Jun 6;93(11):858-65.

PMID:
11390535
15.

Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.

Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Göke B, Lamerz R, Kolligs FT.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):142-9.

PMID:
15704048
16.

Development of novel diagnostic and prognostic molecular markers for sporadic colon cancer.

Ahmed FE.

Expert Rev Mol Diagn. 2005 May;5(3):337-52. Review.

PMID:
15934812
17.

Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

Campbell-Thompson M, Lynch IJ, Bhardwaj B.

Cancer Res. 2001 Jan 15;61(2):632-40.

18.

Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR.

Solmi R, De Sanctis P, Zucchini C, Ugolini G, Rosati G, Del Governatore M, Coppola D, Yeatman TJ, Lenzi L, Caira A, Zanotti S, Taffurelli M, Carinci P, Valvassori L, Strippoli P.

Int J Oncol. 2004 Oct;25(4):1049-56.

PMID:
15375555
19.

Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.

Kontos CK, Papadopoulos IN, Scorilas A.

Biol Chem. 2008 Dec;389(12):1467-75. doi: 10.1515/BC.2008.173.

PMID:
18844453
20.

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD.

J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32.

PMID:
16077070

Supplemental Content

Support Center